Patent application number | Description | Published |
20090029960 | MACROCYCLIC COMPOUNDS USEFUL AS BASE INHIBITORS - The invention relates to novel macrocyclic compounds of the formula | 01-29-2009 |
20090054467 | Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases - The invention provides compounds of Formula I or a pharmaceutically acceptable salt or ester thereof wherein the symbols have meaning as defined, which are inhibitors of cathepsin K and find use pharmaceutically for treatment of diseases and medical conditions in which cathepsin K is implicated, e.g. various disorders including inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors. | 02-26-2009 |
20100022500 | Macrocyclic Lactams and Pharmaceutical Use Thereof - The present invention relates to novel macrocyclic compounds of the formula | 01-28-2010 |
20100222396 | 4-ARYL-BUTANE-1,3-DIAMIDES - The invention relates to compound of the formula I | 09-02-2010 |
20120101110 | Diaza-spiro[5.5]undecanes - The invention relates to compound of the formula I | 04-26-2012 |
20120165331 | Di/tri-aza-spiro-C9-C11alkanes - The invention relates to compounds of the formula I | 06-28-2012 |
20120258973 | DISUBSTITUTED HETEROARYL-FUSED PYRIDINES - The invention relates to compound of the formula (I′) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it. | 10-11-2012 |
20120264748 | DIAZA-SPIRO[5.5]UNDECANES - The invention relates to compound of the formula (I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it. | 10-18-2012 |
20130281463 | DIAZA-SPIRO[5.5]UNDECANES USEFUL AS OREXIN RECEPTOR ANTAGONISTS - The invention relates to compound of the formula (I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it. | 10-24-2013 |